Welcome to our blog community! This blog will show you how CED is helping emerging companies scale and grow in the Research Triangle Region. Plus we post news about our members and entrepreneurial resources.
Novan, a spinout from UNC-Chapel Hill, has closed on $6 million in new capital, according to a filing with the SEC. Investors include Cree co-founder Neal Hunter, Cree executive John Palmour and former life science executive Robert Ingram. Novan is focused on products to counter drug-resistant infections. Dr. Mark Schoenfish of UNC-CH is a co-founder. Novan raised $4 million in January. The latest funding is a mix of equity and options, according to the SEC filing.